1501-13-9 Usage
Uses
Used in Pharmaceutical Research:
7-PHENYL-2,4,9-TRIAZABICYCLO[4.3.0]NONA-1,3,5,7-TETRAEN-5-AMINE is used as a research compound for exploring its potential pharmacological properties and therapeutic applications. Its unique structure and the presence of a phenyl group may offer opportunities for the development of new drugs or drug candidates.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 7-PHENYL-2,4,9-TRIAZABICYCLO[4.3.0]NONA-1,3,5,7-TETRAEN-5-AMINE is used as a starting material or a building block for the synthesis of more complex molecules with potential therapeutic effects. Its chemical reactivity and the possibility of modifying its structure make it a valuable tool for designing new drugs.
Used in Drug Discovery:
7-PHENYL-2,4,9-TRIAZABICYCLO[4.3.0]NONA-1,3,5,7-TETRAEN-5-AMINE is used in drug discovery processes to identify its potential as a lead compound for the development of new pharmaceuticals. Its biological activities and interactions with biological targets need to be thoroughly investigated to determine its suitability as a drug candidate.
Used in Chemical Synthesis:
In chemical synthesis, 7-PHENYL-2,4,9-TRIAZABICYCLO[4.3.0]NONA-1,3,5,7-TETRAEN-5-AMINE can be used as an intermediate or a precursor in the synthesis of other related compounds with potential applications in various fields, including pharmaceuticals, agrochemicals, and materials science.
Note: Since the provided materials do not specify any particular application or industry for 7-PHENYL-2,4,9-TRIAZABICYCLO[4.3.0]NONA-1,3,5,7-TETRAEN-5-AMINE, the uses listed above are general and based on the potential of the compound as described in the materials. Further research and development may reveal more specific applications in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 1501-13-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,5,0 and 1 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1501-13:
(6*1)+(5*5)+(4*0)+(3*1)+(2*1)+(1*3)=39
39 % 10 = 9
So 1501-13-9 is a valid CAS Registry Number.
InChI:InChI=1/C12H10N4/c13-11-10-9(8-4-2-1-3-5-8)6-14-12(10)16-7-15-11/h1-7H,(H3,13,14,15,16)
1501-13-9Relevant academic research and scientific papers
Synthesis of 2,6-Substituted 7-(Het)aryl-7-deazapurine Nucleobases (2,4-Disubstituted 5-(Het)aryl-pyrrolo[2,3- d ]pyrimidines)
Sabat, Nazarii,Smoleń, Sabina,Nau?, Petr,Perlíková, Pavla,Cebová, Magdaléna,Po?tová Slavětínská, Lenka,Hocek, Michal
, p. 4623 - 4650 (2017/10/06)
A series of 7-(het)aryl-7-deazapurine nucleobases (5-[(het)aryl]-2,4-disubstituted 7 H -pyrrolo[2,3- d ]pyrimidines) bearing NH 2, OMe, SMe, or Me groups at position 6 and H, NH 2, or Me at position 2 were prepared by the aqueous Suzuki-Miyaura cross-coupling reactions from SEM-protected 7-iodo-7-deazapurines with (het)arylboronic acids followed by deprotection. The 6-methoxy derivatives were further transformed into 7-deazahypoxanthines or 7-deazaguanines by O -demethylation reactions. Unlike their ribonucleoside counterparts, the 7-deazapurine nucleobases did not exert any significant cytostatic or antiviral effects.
7-alkyl- and 7-cycloalkyl-5-aryl-pyrrolo[2,3-d]pyrimidines - Potent inhibitors of the tyrosine kinase c-Src
Widler, Leo,Green, Jonathan,Missbach, Martin,Susa, Mira,Altmann, Eva
, p. 849 - 852 (2007/10/03)
7-Substituted-5-aryl-pyrrolo[2,3-d]pyrimidines have been prepared starting from α-bromoacetophenones. These compounds represent a novel class of potent inhibitors of the tyrosine kinase pp60c-Src with good specificity towards other tyrosine kinases (EGF-R, v-Abl).
